Mark Charest's guest appearances

Mark Charest

Valuewalk's ValueTalks

Jeff Dorman

Nolan Bauerle

Charlie Munger

Kevin Kelly

Chris White

Keith Smith

Bill Browder

Nassim Nicholas Taleb

Gregory Zuckerman

Guy Davis

Jeremy Schwartz

Scott Miller

Howard Marks

Tavi Costa

Will Rhind

OwlTail

Paul Yook

Hello Podcast Listners,Today is a very special episode with Paul Yook, CIO of LifeSci Venture Partners and Mark Charest, Portfolio Manager and Founding Partner of LifeSci Fund Management. Paul has over 20 years of healthcare investment and finance experience. He founded LifeSci Venture Partners in 2017 and launched BioShares biotechnology ETFs in 2014.. Paul earned his Bachelor in Science in Economics and Bachelor of Arts in Biochemistry from the University of Pennsylvania. Dr. Charest has a distinguished scientific background and brings over a decade of institutional healthcare investing experience. He is the inventor of 8 drug patents. He earned his Bachelors in Chemistry with highest honors from Rutgers and his PhD in Chemistry and Chemical Biology from Harvard. In today’s episode we discuss the recent launch of the Biothreat ETF and how they approach the healthcare industry.  Enjoy and thanks for the listen!

Hello Podcast Listners,<br><br>Today is a very special episode with Paul Yook, CIO of LifeSci Venture Partners and Mark Charest, Portfolio Manager and Founding Partner of LifeSci Fund Management. Paul has over 20 years of healthcare investment and finance experience. He founded LifeSci Venture Partners in 2017 and launched BioShares biotechnology ETFs in 2014.. Paul earned his Bachelor in Science in Economics and Bachelor of Arts in Biochemistry from the University of Pennsylvania. Dr. Charest has a distinguished scientific background and brings over a decade of institutional healthcare investing experience. He is the inventor of 8 drug patents. He earned his Bachelors in Chemistry with highest honors from Rutgers and his PhD in Chemistry and Chemical Biology from Harvard. In today’s episode we discuss the recent launch of the Biothreat ETF and how they approach the healthcare industry.  <br><br>Enjoy and thanks for the listen!

Biotech Investing with Paul Yook, CIO of LifeSci Venture Partners and Mark Charest, PM